AXL and Zika virus infectious disease: However, incomplete inhibition of ZIKV infection in cells pre-treated with an anti GRP78 N-terminal antibody and no effect of down regulation of GRP78 to viral binding or/and entry level may suggest that ZIKV uses multiple molecules during entry into the cell, consistent with previous studies that have characterized AXL as ZIKV receptor on A549 cells17.